Acidic polyanion poly(acrylic acid) prevents calcium oxalate crystal deposition

Kidney International

Volumn 74, Issue 7, 2008, Pages 919-924

  Kleinman, Jack G ^a   Alatalo, Laura J ^a   Beshensky, Ann M ^a   Wesson, Jeffrey A ^a  

^a CLEMENT J ZABLOCKI VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Biomineralization; Calcium; Crystallization; Kidney stones; Oxalate

Indexed keywords

CALCIUM OXALATE; CREATININE; POLYACRYLIC ACID; SODIUM CHLORIDE;

ACIDITY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOTINYLATION; CONTROLLED STUDY; CREATININE BLOOD LEVEL; CREATININE URINE LEVEL; CRYSTALLIZATION; IN VITRO STUDY; IN VIVO STUDY; KIDNEY CALCIFICATION; MALE; MICROSCOPY; NEPHROLITHIASIS; NONHUMAN; OSMOTIC MINIPUMP; PRIORITY JOURNAL; RAT; URINARY EXCRETION;

ACRYLIC RESINS; ANIMALS; CALCIUM OXALATE; CRYSTALLIZATION; KIDNEY CALCULI; MALE; POLYMERS; RATS; RATS, SPRAGUE-DAWLEY; URINE;

EID: 51849085221     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1038/ki.2008.253     Document Type: Article

References (30)

1. Khan SR. Experimental calcium oxalate nephrolithiasis and the formation of human urinary stones. [Review]. Scanning Microsc 1995; 9: 89-101.
2. Evan AP, Lingeman JE, Coe FL et al. Randall's plaque of patients with nephrolithiasis begins in basement membranes of thin loops of Henle. J Clin Invest 2003; 111: 607-616.
3. Khan SR. Structure and development of calcific urinary stones. chap. 14, In: Bonucci E (eds). Calcification in Biological Systems. CRC Press Inc.: Boca Raton, 1992, pp 345-363.
4. Khan SR. Interactions between stone-forming calcific crystals and macromolecules. Urol Int 1997; 59: 59-71.
5. Worcester EM, Blumenthal SS, Beshensky AM et al. The calcium oxalate crystal growth inhibitor protein produced by mouse kidney cortical cells in culture is osteopontin. J Bone Miner Res 1992; 7: 1029-1036.
6. Nakagawa Y, Abram V, Kezdy FJ et al. Purification and characterization of the principal inhibitor of calcium oxalate monohydrate crystal growth in human urine. J Biol Chem 1983; 258: 12594-12600.
7. Ryall RL, Grover PK, Stapleton AM et al. The urinary F1 activation peptide of human prothrombin is a potent inhibitor of calcium oxalate crystallization in undiluted human urine in vitro. Clin Sci 1995; 89: 533-541.
8. Atmani F, Mizon J, Khan SR. Identification of uronic-acid-rich protein as urinary bikunin, the light chain of inter-alpha-inhibitor. Eur J Biochem 1996; 236: 984-990.
9. Ryall RL, Harnett RM, Marshall VR. The effect of urine, pyrophosphate, citrate, magnesium and glycosaminoglycans on the growth and aggregation of calcium oxalate crystals in vitro. Clin Chim Acta 1981; 112: 349-356.
10. Robertson WG, Peacock M. Calcium oxalate crystalluria and inhibitors of crystallization in recurrent renal stone-formers. Clin Sci 1972; 43: 499-506.
11. Pak CY, Holt K. Nucleation and growth of brushite and calcium oxalate in urine of stone-formers. Metabolism 1976; 25: 665-673.
12. Robertson WG, Peacock M, Marshall RW et al. Saturation-inhibition index as a measure of the risk of calcium oxalate stone formation in the urinary tract. N Engl J Med 1976; 294: 249-252.
13. Wesson JA, Worcester E. Formation of hydrated calcium oxalates in the presence of poly-L-aspartic acid. Scanning Microsc 1996; 10: 415-424.
14. Wesson JA, Worcester EM, Kleinman JG. Role of anionic proteins in kidney stone formation: interaction between model anionic polypeptides and calcium oxalate crystals. J Urol 2000; 163: 1343-1348.
15. Guo S, Ward MD, Wesson JA. Direct visualization of calcium oxalate monohydrate crystallization and dissolution with atomic force microscopy and the role of polymeric additives. Langmuir 2002; 18: 4284-4291.
16. Wesson JA, Ganne V, Beshensky AM et al. Regulation by macromolecules of calcium oxalate crystal aggregation in stone formers. Urol Res 2005; 33: 206-212.
17. Qiu SR, Wierzbicki A, Orme CA et al. Molecular modulation of calcium oxalate crystallization by osteopontin and citrate. Proc Natl Acad Sci USA 2004; 101: 1811-1815.
18. Sheng X, Ward MD, Wesson JA. Adhesion between molecules and calcium oxalate crystals: critical interactions in kidney stone formation. J Am Chem Soc 2003; 125: 2854-2855.
19. Jung T, Sheng X, Choi CK et al. Probing calcium oxalate monohydrate crystal growth and the role of macromolecular additives with in situ atomic force microscopy. Langmuir 2004; 20: 8587-8596.
20. Wesson JA, Johnson RJMM, Beshensky AM et al. Osteopontin is a critical inhibitor of calcium oxalate crystal formation and retention in renal tubules. J Am Soc Nephrol 2003; 14: 139-147.
21. Khan SR. Animal models of kidney stone formation: an analysis. [Review] [52 refs]. World J Urol 1997; 15: 236-243.
22. Wesson JA, Worcester EM, Wiessner JH et al. Control of calcium oxalate crystal structure and cell adherence by urinary macromolecules. Kidney Int 1998; 53: 952-957.
23. Lieske JC, Leonard R, Toback FG. Adhesion of calcium oxalate monohydrate crystals to renal epithelial cells is inhibitied by specific anions. Am J Physiol (Renal Fluid Electrolyte Physiol) 1995; 268: F604-F612.
24. Bigelow MW, Wiessner JH, Kleinman JG et al. Surface exposure of phosphatidylserine increases calcium oxalate crystal attachment to IMCD cells. Am J Physiol (Renal Fluid Electrolyte Physiol) 1997; 272: F55-F62.
25. Verkoelen CF, van der Boom BG, Romijn JC. Identification of hyaluronan as a crystal-binding molecule at the surface of migrating and proliferating MDCK cells. Kidney Int 2000; 58: 1045-1054.
26. Kumar V, Farell G, Deganello S et al. Annexin II is present on renal epithelial cells and binds calcium oxalate monohydrate crystals. J Amer Soc Neph 2003; 14: 289-297.
27. Sorokina EA, Wesson JA, Kleinman JG. An acidic peptide sequence of nucleolin-related protein can mediate the attachment of calcium oxalate to renal tubule cells. J Am Soc Nephrol 2004; 15: 2057-2065.
28. Kok DJ, Khan SR. Calcium oxalate nephrolithiasis, a free or fixed particle disease. Kidney Int 1994; 46: 847-854.
29. Mo L, Huang HY, Zhu XH et al. Tamm-Horsfall protein is a critical renal defense factor protecting against calcium oxalate crystal formation. Kidney Int 2004; 66: 1159-1166.
30. DePass LR, Garman RH, Woodside MD et al. Chronic toxicity and oncogenicity studies of ethylene glycol in rats and mice. Fundam Appl Toxicol 1986; 7: 547-565.